Share-based Payment Arrangement, Expense in USD of RayzeBio, Inc. from Q3 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
RayzeBio, Inc. quarterly Share-based Payment Arrangement, Expense history and change rate from Q3 2022 to Q3 2023.
  • RayzeBio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2023 was $2,564,000, a 77% increase year-over-year.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

RayzeBio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $2,564,000 +$1,117,000 +77% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q3 2022 $1,447,000 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.